Remission Maintenance Therapy for Meningeal Leukemia : 680 BLooD

  • Margaret, TERESA J. VIEYrI, +6 authors GEHAN
  • Published 2005
Central nervous system infiltrates have become a major cause of morbidity among leukemic children and may constitute a site from which a remission marrow is again infiltrated. Conventional intrathecal methotrexate (IT MTX) therapy produces excellent palliation and complete reversal of abnormal cerebrospinal fluid findings for periods ranging from 6 to 414… (More)